Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
CING
#4241
Cingulate Inc. Common Stock
5.350
0
USD
-2.73%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
-2.73%
Aylık Değişim
-46.01%
6 aylık değişim
-13.15%
Yıllık Değişim
-13.15%
Önceki Kapanış
5.500
0
Open
5.350
0
Bid
Ask
Low
5.350
0
High
5.350
0
Hacim
18
Piyasalar
ABD Borsası
Sağlık Hizmetleri
CING
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
47.12 K
47.12 K
417.54 K
3.77 M
11.63 M
—
Valuation ratios
Enterprise value
15.85 M
12.01 M
36.21 M
11.34 M
46.96 M
102.57 M
Price to earnings ratio
—
-0.65
-0.26
-0.48
-0.98
5.46
Price to sales ratio
—
—
—
—
-10.12
—
Price to cash flow ratio
—
-0.73
-0.4
-0.41
-1.27
-2.98
Price to book ratio
—
2.97
-0.89
1.01
8.74
9.72
Enterprise value to EBITDA ratio
—
—
—
—
-3.84
—
Profitability ratios
Return on assets %
-0.9
-1.55
-6.74
-1.05
-1.49
-1.77
Return on equity %
-0.99
-4.55
3.43
-2.09
-8.95
-6.12
Return on invested capital %
-1 496.72
-971.12
-1 199.49
-1 123.26
-1 103.5
-1 119.32
Gross margin %
—
—
—
—
100
—
Operating margin %
—
—
—
—
920.04
—
EBITDA margin %
—
—
—
—
580.03
—
Net margin %
—
—
—
—
1 035.95
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
16.05
1.12
0.06
2.55
1.16
5.82
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
-0.14
—
Solvency ratios
Debt to assets ratio
0.05
0.51
0.74
0.33
0.49
1.58
Debt to equity ratio
0.05
1.5
-0.38
0.67
2.97
5.67
Long term debt to total assets ratio
0
0.44
0.6
0.33
0.49
1.58
Long term debt to total equity ratio
0
1.29
-0.31
0.67
2.97
5.67
Per share metrics
Operating cash flow per share
—
-337.05
-199.3
-12.1
-3.41
-3.85
EBIT per share
—
—
—
—
-2.6
—
EBITDA per share
—
—
—
—
-2.49
—
Total debt per share
—
123.69
34.32
3.26
1.47
4.61
Cash per share
—
113.67
0.69
8.01
2.17
7.93
Net current asset value per share
—
167
7.67
8.3
2.38
8.95
Tangible book value per share
—
82.38
-91.06
4.89
0.5
4.02
Working capital per share
—
18.18
-127.89
5.04
0.34
2.76
Book value per share
—
82.38
-91.06
4.89
0.5
4.02
Haberler
Cingulate, At-The-Market teklifini 31,9 milyon dolara yükseltti
Cingulate increases at-the-market offering limit to $31.9 million
Cingulate, Shane Schaffer’ı CEO olarak yeniden atadı, istihdam şartlarını güncelledi
Cingulate reinstates Shane Schaffer as CEO, updates employment terms
Cingulate appoints new CCO, secures $6 million financing
Cingulate’s ADHD drug meets primary endpoints in phase 3 trial
FDA, Cingulate’ın DEHB ilacı başvurusunu kabul etti, hedef tarih Mayıs 2026
FDA accepts Cingulate’s ADHD drug application, sets May 2026 target date
Cingulate, DEHB ilacı için Bend Bio Sciences ile üretim anlaşması imzaladı
Cingulate secures manufacturing deal with Bend Bio Sciences for ADHD drug
Cingulate issues shares to lender in series of unregistered transactions
Cingulate appoints John A. Roberts as executive chairman, CEO placed on leave